Immediate Impact
4 from Science/Nature 66 standout
Citing Papers
Chemistry, structure and function of approved oligonucleotide therapeutics
2023 Standout
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial
2022 Standout
Works of ST Iannaccone being referenced
Intragenic telSMN Mutations: Frequency, Distribution, Evidence of a Founder Effect, and Modification of the Spinal Muscular Atrophy Phenotype by cenSMN Copy Number
1998
Function changes in spinal muscular atrophy II and III
1996
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| ST Iannaccone | 219 | 271 | 7 | 127 | 9 | 299 | |
| Melissa Menier | 203 | 227 | 26 | 149 | 8 | 321 | |
| Maria Mazurkiewicz-Bełdzińska | 121 | 186 | 7 | 104 | 15 | 205 | |
| Kavitha Kotha | 142 | 127 | 9 | 87 | 13 | 305 | |
| Natalie F. Reash | 196 | 138 | 46 | 89 | 20 | 278 | |
| David Mihal | 157 | 199 | 6 | 123 | 10 | 290 | |
| Jena M. Krueger | 117 | 142 | 15 | 91 | 12 | 206 | |
| Ai Sakonju | 93 | 137 | 3 | 99 | 8 | 195 | |
| Kathrin Kizina | 162 | 265 | 5 | 160 | 12 | 301 | |
| Eva Also‐Rallo | 207 | 224 | 7 | 106 | 11 | 287 | |
| Yasuo Hachiya | 103 | 70 | 5 | 35 | 12 | 197 |
All Works
Loading papers...